LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cash and cameras: a new way to beat latent TB?
Disease control Recruiting nowThis study tests whether offering small financial rewards and using video calls to watch people take their medicine can help more people complete treatment for latent tuberculosis. About 399 adults in Baltimore will be randomly assigned to usual care, video check-ins alone, or vi…
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a 1-Month pill course stop TB in schools?
Disease control Recruiting nowThis study tests whether a 4-week course of two TB drugs works as well as the standard 3-month course to prevent active TB in students and staff who have been exposed. About 3,520 people from schools will take either the short or standard regimen. The goal is to see if the shorte…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
TB prevention breakthrough? 6-Week regimen could replace months of treatment
Prevention Recruiting nowThis study compares a new 6-week daily rifapentine regimen to the standard 12-16 week rifamycin-based treatment for latent tuberculosis infection (LTBI). The goal is to see if the shorter treatment is just as safe and effective at preventing active TB. About 3,400 people at highe…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Matched conditions: LATENT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks hidden infections in migrants
Knowledge-focused Recruiting nowThis study looks at how common certain infections are among 250 asylum seekers living in reception centers in Italy. Participants must be adults who arrived in Italy between 2 and 36 months ago. The goal is to better understand infection rates to improve health screening and care…
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: IRCCS Sacro Cuore Don Calabria di Negrar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC